Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beiersdorf Eucerin plus Rx topical steroid reduces cost of atopic dermatitis -- study.

This article was originally published in The Tan Sheet

Executive Summary

EUCERIN USE WITH Rx STEROID FOR ATOPIC DERMATITIS CUTS COSTS BY HALF for consumers by reducing steroid application from twice- to once-daily through the added use of the water-in-emollient moisturizer, according to results of a study performed by Anne Lucky, MD, et al., Dermatology Research Associates (Cincinnati, Ohio). Published in the July/August 1997 issue of Pediatric Dermatology, the study evaluated comparative regimens of once-daily application each of prescription hydrocortisone 2.5% cream and Beiersdorf's Eucerin Original Creme against twice-daily application of the hydrocortisone treatment in 25 children with mild to moderate atopic dermatitis. The regimens were found to be of "equivalent" efficacy. Rx steroid treatments cost between $10 to $30 per ounce, while water-in-oil moisturizers such as Eucerin average around $1 an ounce, the researchers said.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087445

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel